Skip to main content
Caplight Logo









The Protocole

The Protocole

Private
New York City, New YorkHealthcare & Life Scienceshttps://theprotocole.com/

Last Round

Seed

Apr 14, 2026

Total Funding Raised

$6M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

The Protocole is a health technology company that provides an exclusive membership platform for clinician-guided access to medical-grade peptide protocols.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, D2C Brands, Precision Medicine, Subscription Commerce, Sports & Fitness

Business Model

B2C

Customer Profile

Usage-Based SaaS, Subscription SaaS

AI Layer

Application

Keywords

telehealthpeptide therapyD2C telehealthbiohackingpersonalized medicinelongevity clinicweight managementcompounding pharmacyhealth optimizationwellness membershipGLP-1clinical supportsubscription healthcare

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

The Protocole Comparables

Compare The Protocole with similar companies based on industry and business-model similarity.

The Protocole comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ivy Rx
87%
Live Vital
85%
Form Blends LLC
85%

The Protocole Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedApr 14, 2026

The Protocole Investors

Notable investors and investment history

The Protocole investors
InvestorRounds
Rare CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 14, 2026

    Raised $6M led by Rare Capital

The Protocole Filings

Explore SEC and related filing metadata, where available.

The Protocole filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about The Protocole's valuation, stock price, and market status.

Is The Protocole a public or private company?

The Protocole is a private company.

What is the current stock price of The Protocole?

The Protocole is a private company with no public stock price. No recent secondary market data is available.

How much is The Protocole worth (valuation)?

Valuation information for The Protocole is not publicly available.

Can I buy The Protocole stock?

The Protocole shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was The Protocole's last funding round?

The Protocole's most recent funding round was Seed on April 14, 2026.

Who are the main investors in The Protocole?

Key investors in The Protocole include Rare Capital.

Will The Protocole IPO soon?

No public IPO plans have been announced for The Protocole.

How can I track The Protocole secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor The Protocole's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range5
Year Founded2025
Last FundingApr 14, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?